Table 2 Univariate and multivariate analyses of relapse-free survival.
Variable | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |
Sex (male/female) | 1.237 | 0.405–3.782 | 0.709 | |||
Preoperative CEA (≥ 5/< 5) | 5.810 | 1.748–19.31 | 0.004 | 2.484 | 0.662–9.314 | 0.177 |
Primary tumor site (rectum/colon) | 0.746 | 0.205–2.713 | 0.657 | |||
Tumor invasion (T3–4/Tis, T1–2) | 2.510 | 0.691–9.124 | 0.162 | |||
Lymph node metastasis (present/absent) | 5.114 | 1.573–16.63 | 0.007 | 1.358 | 0.322–5.718 | 0.677 |
Lymphatic invasion (present/absent) | 4.336 | 0.961–19.57 | 0.056 | |||
Venous invasion (present/absent) | 6.854 | 2.109–22.28 | 0.001 | 4.251 | 1.114–16.22 | 0.034 |
ARC expression (positive/negative) | 4.677 | 1.528–14.31 | 0.007 | 5.306 | 1.366–20.61 | 0.016 |